Malladi Drugs & Pharmaceuticals Limited
Malladi Drugs & Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, is headquartered in India. Established in 1980, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a strong focus on quality and innovation, Malladi offers a diverse range of products, including anti-infectives, anti-diabetics, and cardiovascular medications. Their commitment to research and development has positioned them as a trusted supplier in the global pharmaceutical landscape. Recognised for their adherence to stringent regulatory standards, Malladi Drugs & Pharmaceuticals has achieved notable milestones, including certifications from major international regulatory bodies. This dedication to excellence has solidified their reputation as a reliable partner in the healthcare sector.
DitchCarbon Score
How does Malladi Drugs & Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Malladi Drugs & Pharmaceuticals Limited's score of 0 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Malladi Drugs & Pharmaceuticals Limited's reported carbon emissions
Malladi Drugs & Pharmaceuticals Limited, headquartered in India, currently does not have available carbon emissions data for the most recent year. However, the company has made significant climate commitments, including a pledge to achieve net-zero emissions across all scopes by 2050. This commitment was formalised in 2023, aligning with the Science Based Targets initiative (SBTi) framework. While specific reduction targets have not been disclosed, Malladi Drugs & Pharmaceuticals is actively working towards integrating sustainability into its operations. The company's long-term strategy reflects a growing recognition of the importance of addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. As they progress towards their net-zero goal, further details on their emissions and reduction initiatives may become available, showcasing their commitment to environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Malladi Drugs & Pharmaceuticals Limited is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
